Beom Joon [BJ] Kim retweeted
Quantitative volumetry outperformed ASPECTS for prognostication in large-core #stroke and identified an infarct volume >110 mL as a potential threshold beyond which the benefit of EVT becomes negligible. ahajrnls.org/4fxH3jX
@doohyuk_kwon @KimBJstroke @SeoulNatlUni
Even after complete recanalization, infarct volume grew by 86% and was associated with worse 90-day outcome. @KimBJstroke ahajrnls.org/4xyP7su
Beom Joon [BJ] Kim retweeted
いつ早期が遅すぎるのか?軽度脳卒中と一過性脳虚血発作後のデュアル反血小板療法ではタイミングが重要だ
この#BloggingStroke投稿では、Anel KarisikがShinらによる#Strokeの記事を議論しています @KimBJstroke @doohyuk_kwon
When Is Early Too Late? Timing Matters for Dual Antiplatelet Therapy After Minor Stroke and TIA
In this #BloggingStroke post, Anel Karisik discusses #Stroke article by Shin et al. @KimBJstroke @doohyuk_kwon ahajournals.org/do/10.1161/b…
Beom Joon [BJ] Kim retweeted
Beyond ASPECTS: Quantifying Net Water Uptake in Large Core Ischemic Stroke
In this #BloggingStroke post, @drchloemutimer discusses #Stroke article by Gwak et al. @KimBJstroke ahajournals.org/do/10.1161/b…
Beom Joon [BJ] Kim retweeted
ICYMI: Check out #Stroke #EditorPick, "Timing of Initiation and Efficacy of Dual Antiplatelet Therapy in Minor Stroke or High-Risk TIA." @KimBJstroke ahajournals.org/doi/full/10.…
In an observational cohort study, earlier initiation of DAPT was associated with the greatest clinical benefit, consistent with current guideline recommendations. @KimBJstroke #stroke ahajrnls.org/3ZbSW7o
Great to be at #ISC2026. The fireside chat sessions translate surprisingly well to commute listening. This year's Science on Demand platform also offers MP3 downloads — a small but very practical upgrade. 🎧 #StrokeTwitter
Beom Joon [BJ] Kim retweeted
I thank Prof. Noguera for citing my article in the ORIENTAL-MeVO trial introduction at #ISC2026. Emerging evidence suggests EVT benefits #stroke patients with DMVO, particularly those with high NIHSS scores.
🔗 ahajournals.org/doi/10.1161/…
Beom Joon [BJ] Kim retweeted
🚨Suboptimal #TICI2c3 reperfusion rates may have been a reason for neutral #MeVO #EVT trial results 🤔*Close association reperfusion grade ➡️90-day mRS* ...check out this paper by Will Diprose and the #EscapeMeVO team👀 jnis.bmj.com/content/early/2…
ORIENT-MeVO showed the benefit of EVT for MeVO, although ACA and PCA occlusions accounted for more than 1/3 of the randomized subjects.
As an international participant at #ISC26, I deeply appreciate AHA/ASA's effort to provide AI-supported real-time translation. This is an important step toward broader global engagement.
Bridging TNK before EVT may not be an option… TNK-PLUS trial at #ISC26
TNK is beneficial for non~LVO after 4.5 hours. #isc26 OPTION trial
Finally, we have a new weapon. OCEANIC trial showed benefit and safety of Asundexian
#ISC26
What I enjoy about #ISC26 : casual hallway catch-ups with colleagues from around the world, and the deeper conversations over coffee and Po-Boy. Love hearing results that could reshape clinical practice, and glimpsing the brilliant minds pushing the boundaries of what we know.
#ISC26 marks my 20th year since first attending as a neurology resident. The annual February ritual, flying across the Pacific, still takes its toll on my body clock. But the ISC has grown bigger, better, richer in science. Twenty years in, and I'm still learning as much as ever.
For years, I've been coming to ISC to sit down and learn. This year, as a Program Committee member, I had the chance to give back, even if in a small way. Seeing the results of that work here and there is rewarding. With the sessions from #ISC26, I hope to do more in Houston.
FVIIa decreased ICH volume growth but no gain in functional outcome. #isc26 Better trends in cases with earlier administration and with spot signs
CHOICE-2 proved the benefit of adjuvant thrombolysis after EVT #isc26































